C K Rumboll1, R A Dyer2, C J Lombard3. 1. Department of Anaesthesia, University of Cape Town, Cape Town, South Africa. Electronic address: crumboll@gmail.com. 2. Department of Anaesthesia, University of Cape Town, Cape Town, South Africa. 3. Biostatistics Unit, South African Medical Research Council, Cape Town, South Africa.
Abstract
BACKGROUND:Oxytocin causes clinically significant hypotension and tachycardia. This study examined whether prior administration of phenylephrine obtunds these unwanted haemodynamic effects. METHODS:Forty pregnant women undergoing elective caesarean section under spinal anaesthesia were randomised to receive either an intravenous 50 μg bolus of phenylephrine (Group P) or saline (Group S) immediately before oxytocin (3U over 15s). Systolic blood pressure, diastolic blood pressure, mean arterial pressure and heart rate were recorded using a continuous non-invasive arterial pressure device. Baseline values were averaged for 20s post-delivery. Between-group comparisons were made of the mean peak changes in blood pressure and heart rate, and the mean percentage changes from baseline, during the 150s after oxytocin administration. RESULTS: The mean ± SD peak percentage change in systolic blood pressure was -16.9 ± 2% in Group P, and -19.0 ± 1.9% in Group S and the estimated mean difference was 2.1% (95% CI -3.5% to 7.8%; P=0.44); corresponding changes in heart rate were 13.5 ± 2.3% and 14.0±1.5% and the mean estimated difference was 0.5% (95% CI -6.0% to 5%; P=0.87). The mean percentage change from the baseline measurements during the 150s period of measurement was greater for Group S than Group P: systolic blood pressure -5.9% vs -3.4% (P=0.149); diastolic blood pressure -7.2% vs -1.5% (P=0.014); mean arterial pressure -6.8% vs -1.5% (P=0.007); heart rate 2.1% vs -2.4% (P=0.033). CONCLUSION:Intravenous phenylephrine 50 μg immediately before 3U oxytocin during elective caesarean section does not prevent maternal hypotension and tachycardia.
RCT Entities:
BACKGROUND: Oxytocin causes clinically significant hypotension and tachycardia. This study examined whether prior administration of phenylephrine obtunds these unwanted haemodynamic effects. METHODS: Forty pregnant women undergoing elective caesarean section under spinal anaesthesia were randomised to receive either an intravenous 50 μg bolus of phenylephrine (Group P) or saline (Group S) immediately before oxytocin (3U over 15s). Systolic blood pressure, diastolic blood pressure, mean arterial pressure and heart rate were recorded using a continuous non-invasive arterial pressure device. Baseline values were averaged for 20s post-delivery. Between-group comparisons were made of the mean peak changes in blood pressure and heart rate, and the mean percentage changes from baseline, during the 150s after oxytocin administration. RESULTS: The mean ± SD peak percentage change in systolic blood pressure was -16.9 ± 2% in Group P, and -19.0 ± 1.9% in Group S and the estimated mean difference was 2.1% (95% CI -3.5% to 7.8%; P=0.44); corresponding changes in heart rate were 13.5 ± 2.3% and 14.0±1.5% and the mean estimated difference was 0.5% (95% CI -6.0% to 5%; P=0.87). The mean percentage change from the baseline measurements during the 150s period of measurement was greater for Group S than Group P: systolic blood pressure -5.9% vs -3.4% (P=0.149); diastolic blood pressure -7.2% vs -1.5% (P=0.014); mean arterial pressure -6.8% vs -1.5% (P=0.007); heart rate 2.1% vs -2.4% (P=0.033). CONCLUSION: Intravenous phenylephrine 50 μg immediately before 3U oxytocin during elective caesarean section does not prevent maternal hypotension and tachycardia.
Authors: Cheryl Chooi; Julia J Cox; Richard S Lumb; Philippa Middleton; Mark Chemali; Richard S Emmett; Scott W Simmons; Allan M Cyna Journal: Cochrane Database Syst Rev Date: 2020-07-01
Authors: Ranjitha Gangadharaiah; Devika Rani Duggappa; Sudheesh Kannan; S B Lokesh; Karuna Harsoor; K M Sunanda; S S Nethra Journal: Indian J Anaesth Date: 2017-11